China Regenerative Medicine International LimitedHKEX: 8158

Interim Report 2026

· Issued by China Regenerative Medicine International Limited via HKEXnews

Filed with HKEX · Stock code 8158 · · 42 pages · English and Chinese

Summary by 6ix AI

The report includes unaudited condensed consolidated financial statements, highlighting revenue, gross profit, and profit before tax figures compared to the previous year. It also provides insights into the company's financial position, including total assets and liabilities as of mid-year. The report emphasizes the responsibilities of the directors regarding the accuracy and completeness of the information presented.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

China Regenerative Medicine International Limited on 6ix

Earlier from China Regenerative Medicine International

Later from China Regenerative Medicine International

All China Regenerative Medicine International news releases